LSCD-101

N/A

Report date: 2026/01/14 20:00:44

Base Information

Drug NameLSCD-101
Drug Alias NameLSCD-101
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCorneal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCliPS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCliPS Co Ltd
Active IndicationsN/A
Inactive IndicationsCorneal Diseases

Other Information

ATC CodeN/A
Related LinksN/A